AUAS/DAN Diving Medicine Scholarship
The Academy of Underwater Arts & Sciences (AUAS) Announces the
AUAS/DAN Diving Medicine Scholarship
The Academy of Underwater Arts and Sciences (AUAS) is pleased to announce, with matching funds from Divers Alert Network (DAN), the creation of the AUAS/DAN Diving Medicine Research Scholarship. This annual scholarship will encourage research on topics that expand the body of knowledge of human physiology in the marine environment. “The scholarship was created through a generous initial donation from a NOGI Fellow and with the matching funds from DAN, will support important diving medicine research into the future,” stated Dan Orr, President of the AUAS. This annual scholarship provides financial support of up to $10,000. Requests for information or an application for the AUAS/DAN Diving Medicine Scholarship can be sent to firstname.lastname@example.org.
The UHMS Seeks New Director of Its Hyperbaric Facility Accreditation Program
After 16 years of dedicated service, Tom Workman, the current accreditation program director, has announced his intention to retire from the UHMS effective January 1, 2018. While he will be missed, his retirement creates an exciting opportunity for a replacement to take the foundation that he created and raise the program to an even higher level.
Sechrist Industries is our First Diamond Level Corporate Partner
Sechrist was founded over 35 years ago in 1973, by Ron Sechrist, a mechanical engineer with a passion for the research and development of new life-saving medical technologies.
UHMS Annual Scientific Meeting Registration Now Open
JOIN US IN ORLANDO FLORIDA FOR OUR 2018 ANNUAL SCIENTIFIC MEETING!
The UHMS 2018 Annual Scientific Meeting's primary goal is to provide a forum for professional scientific growth and development of the participants to improve knowledge and competence in order to further patient outcome. The meeting provides a basis for exchange of ideas, both scientific and practical, among physicians, researchers, and other health professionals.
Clinical Practice Guidelines Committee at Work
The UHMS CPG Oversight Committee, chaired by Dr. Enoch Huang, has completed work on the first clinical practice guideline for the UHMS: ‘A clinical practice guideline for the use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers.’ The paper is available here: https://www.uhms.org/cpg.
Safety Time Out/Pause - "Stop"
UHMS Position Statement
Safety Timeout and Pause “STOP”
The Safety Committee of the Undersea and Hyperbaric Medical Society recommends that a Safety Time Out / Pause (STOP) be performed prior to the start of every hyperbaric treatment. A STOP should be completed regardless of multiplace or monoplace operations. A STOP will be performed in order to be compliant with safety goals, to combat complacency, and document completion of our unique safety practices. We recommend that the STOP be modeled after the timeouts performed before surgical procedures.
UHMS Credentialing and Privileging Guidelines for Hyperbaric Medicine Physicians in the U.S.A.
UHMS Credentialing and Privileging Guidelines For Hyperbaric Medicine Physicians in the U.S.A.
Revised: 26 June 2014
Principles Intrinsic to Ensuring Patient Access to Safe, High‐Quality Hyperbaric Oxygen (HBO2) Therapy HBO2 therapy entails medical risks and should be provided only by physicians with specialized training in hyperbaric medicine and facilities properly equipped and maintained to do so. For physicians, experience in both routine and emergent HBO2 treatment situations is expected. For facilities, formal accreditation through a facility accreditation program recognized by the Joint Commission, such as the UHMS accreditation program, is recommended. A 5‐year transition period is recommended to enable all hyperbaric medicine physicians and facilities to meet these certification, privileging and accreditation guidelines. However, during this transition period, patient access to HBO2 therapy for approved indications should not be limited.
FDA Position Statement on "Off Label" Conditions: "Hyperbaric Oxygen Therapy: Don't Be Misled"
Sunshine Act starts August 1, 2013
Sunshine Act starts August 1, 2013. Some helpful information can be found at these sites:
A Letter from UHMS President, Dr. John Feldmeier in Response to The recent article by Margolis
A Letter from UHMS President, Dr. John Feldmeier in Response to The recent article by Margolis et al that reports the failure of hyperbaric oxygen in the treatment of diabetic foot ulcers.
Click Here for full Letter
Interpretation of the study "Lack of Effectiveness of Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcer and Prevention of Amputation"
UHMS/CDC Carbon Monoxide Surveillance Project
Neil B. Hampson, MD
After 3 years of operation, the joint project between the UHMS and the US Centers for Disease Control and Prevention (CDC) to conduct online surveillance of cases of carbon monoxide (CO) poisoning treated with hyperbaric oxygen was completed in December 2011. Due to cutbacks in Federal funding for the CDC, financial support was not available for a fourth year. Furthermore, the pilot project had already achieved all of the goals established when it went online in August 2008, and more.